NCT02605187View on ClinicalTrials.gov

Patient-Driven Analgesic Protocol Selection for Post-Cesarean Pain Management

NACompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

May 22, 2017

Study Completion Date

May 22, 2017

Conditions
Postoperative Pain
Interventions
OTHER

No choice given

Patients are randomized to getting a choice or not getting a choice. If they do not get a choice, they receive standard dose.

OTHER

Choice given

Patients are randomized to getting a choice or not getting a choice. If they do get a choice, they will receive the protocol they select.

DRUG

Ibuprofen

Ibuprofen 600mg po q6h

DRUG

Acetaminophen

Acetaminophen 650mg po q6h

DRUG

Gabapentin

Gabapentin 600mg po one time within 1 hour of delivery

DRUG

Morphine (low)

Intrathecal morphine dose 50mcg

DRUG

Morphine (med)

Intrathecal morphine dose 150mcg

DRUG

Morphine (high)

Intrathecal morphine 300mcg

Trial Locations (1)

94305

Lucille Packard Children's Hospital, Palo Alto

All Listed Sponsors
lead

Stanford University

OTHER

NCT02605187 - Patient-Driven Analgesic Protocol Selection for Post-Cesarean Pain Management | Biotech Hunter | Biotech Hunter